Healthcare

COMPASS Pathways plc (CMPS)

$13.33
-6.06%
$1.8B
Market Cap
P/E Ratio
2.40
Beta
Dividend Yield
Piotroski 2/9

Quantitative Summary

Deterministic

Below-average fundamentals indicated by Piotroski score of 2/9.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Technical Setup

AI Generated

Compass Pathways plc is currently trading at $11.81, a position that requires contextual analysis against its moving averages to determine the prevailing trend direction. Without specific average data points in the provided dataset, it remains unclear whether the current price action signifies an uptrend where values sit above key moving averages or a downtrend characterized by prices falling below them. This ambiguity prevents a definitive statement on the immediate trajectory of the stock's momentum based solely on the available figures. The Relative Strength Index (RSI) is not included in the supplied technical indicators, leaving the short-term momentum status unquantified. In the absence of this metric, one cannot ascertain if the asset is experiencing overbought conditions that might suggest a potential pullback or oversold states indicating possible reversal opportunities. The current price level of $11.81 stands as an isolated data point without corroborating trend confirmation from moving averages or momentum signals from the RSI. Consequently, the technical picture for this healthcare sector stock remains indeterminate based on the limited information provided. Market participants would need to integrate additional indicators such as specific moving average crossovers and RSI readings to form a comprehensive view of whether short-term forces are supporting further appreciation or signaling weakness in the current valuation.

RSI (14)
SMA 50
SMA 200

Quant Health Deep Dive

2/9
Piotroski F-Score
Weak — below-average operational and profitability metrics

Balance Sheet Health

-4.98x
Debt / Equity
0.77x
Current Ratio
-63.3x
Interest Coverage
-285.6M
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $-0.49
Act: $-0.42
+14.6%
Q3
✗ Miss
Est: $-0.37
Act: $-0.41
-11.2%
Q2
✓ Beat
Est: $-0.41
Act: $-0.38
+5.3%
Q1
✗ Miss
Est: $-0.39
Act: $-0.61
-55.5%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

-12.4
Forward P/E
PEG Ratio
5.39
Price/Book
4M
Avg Volume
$13.10
52W High
$2.25
52W Low
102%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$33M
Tracked Passive Exposure
2
ETFs Holding CMPS
1.76%
Avg Weight in ETFs
$2B
Total ETF AUM

When investors buy or sell ETFs like ARKG or GWX, the fund manager is mechanically forced to buy or sell CMPS shares regardless of COMPASS Pathways plc's individual fundamentals. We estimate $33M of passive capital is structurally linked to CMPS through 2 tracked ETFs. Passive flows have a limited but growing influence on CMPS's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in COMPASS Pathways plc to visualize passive redemption contagion across ETFs and collateral stocks.

CMPS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
CMPSEpicenterARKGETFGWXETFTWSTLow RiskCRSPLow RiskTEMHigh RiskTXGLow RiskPSNLMed Risk
CMPS Price Drop (%)0

If COMPASS Pathways plc (CMPS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies TWIST BIOSCIENCE CORP (TWST) as the most exposed collateral stock, sharing 1 ETFs with CMPS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

CMPS Ownership Dynamics

Passive funds hold 1 in every 43 CMPS shares, reducing daily market volatility.

Ticker
CMPS
Total Shares
135M
ETF Lock-Up
2.3%
Display Mode
Total Float Impact
2.3%Locked Float

COMPASS Pathways plc (CMPS) exerts measurable gravity on the passive index market, currently representing 3.0% of the ARK Genomic Revolution ETF (ARKG) and 0.1% of the GWX (GWX). Across 2 tracked ETFs, approximately 3M shares (2.3% of float) are held by passive funds and rarely trade on the open market. As passive ownership grows, index inclusion changes may increasingly drive price discovery.

ETFs with Highest CMPS Exposure

Float lock-up computed from 2 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

CMPS Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
CMPS
PRICE
$13.33
FLOOR (POC)
$6.31
STRENGTH
Medium
$38%$3$4$410%$59%$69%$6POC 11%$79%$8$86%$96%$98%$10$11$11$12$13$13$13.33$14$14
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for COMPASS Pathways plc over the past year sits near $6.31 (11% of 252-day volume). The current price of $13.33 trades 111.1% above this institutional floor — a sign of upside momentum, though a pullback to the POC zone is a common reversion target.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1323,994$9.37$224,823.78
2026-05-118,879$9.91$87,990.89
2026-05-0826,502$9.39$248,853.78
2026-05-0718$9.76$175.68
2026-05-0138,381$9.06$347,731.86
2026-04-30187$8.38$1,567.06
2026-04-28521$8.89$4,631.69
2026-04-2739,690$9.58$380,230.2
2026-04-2329,926$8.75$261,852.5
2026-04-2181,356$9.46$769,627.76
2026-04-209,656$6.66$64,308.96
2026-04-1723,416$6.66$155,950.56
2026-03-194,319$5.88$25,395.72
2026-03-1395,181$6.63$631,050.03
2026-03-1249,231$6.89$339,201.59
2026-03-11225,105$7.44$1.7M
2026-03-0356,062$7.02$393,555.24
2026-02-277,603$7.33$55,729.99
2026-02-233,265$8.05$26,283.25
2026-02-18354,480$7.63$2.7M
2026-02-1770,897$5.81$411,911.57
2026-02-0980,497$6.19$498,276.43
2026-02-06990,545$5.71$5.7M
2026-02-0418,797$6.59$123,872.23
2026-02-032,000$6.61$13,220
2026-01-2936,518$6.71$245,035.78
2026-01-2735,288$6.90$243,487.2
2026-01-2341,777$7.13$297,870.01
2026-01-2146,526$7.31$340,105.06
2026-01-201,007$7.35$7,401.45

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare CMPS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.